India erythromycin market is expected
to grow at a substantial rate during the forecast period. Erythromycin is an antibiotic
used to treat certain kind of bacterial infections. The India erythromycin market
is driven by increasing number of drug developments. Moreover, rising prevalence
of various infectious diseases in the country is forecasted to positively
influence the market growth. Continuous research and developmental investments
by pharmaceutical manufacturers is further expected to boost the growth of
India erythromycin market through FY2026.
The India erythromycin market is
segmented based on composition, application, source, form, distribution channel, route of
administration, end user,
company, and region. Based on application, the market can be segmented into respiratory
tract infections, eye infections, ear infections, skin and soft tissue
infection, gastro-intestinal infections and others. Among these, respiratory
tract infections segment is expected to hold the major market share through
FY2026 on account of high prevalence of respiratory tract infections amongst
population. According to National Health Portal of India, acute respiratory
infections accounted for around 69% of the total cases of communicable diseases
in
India in 2019. Therefore, the efficient use of this drug for the treatment of respiratory
infections, is further bolstering the market growth.
The major players operating in the
India erythromycin market are Lupin Laboratories Ltd., Unicure India Private
Ltd., Alkem Laboratories Ltd., Dr. Reddy’s Laboratories Ltd., Centurion
Laboratories Private Ltd., Milan Laboratories India Pvt. Ltd., Systopic
Laboratories Pvt. Ltd., Anuh Pharma Ltd., Envee Drugs Pvt. Ltd., Halycon Labs
Private Limited., and others. Major companies are developing advanced
technologies and launching new products in order to stay competitive in the
market. Other competitive strategies include mergers & acquisitions and new
product developments to expand their geographic reach and to increase their
customer basis.
Years considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the
Study:
- To analyze and estimate the market size of India
erythromycin market from FY2016 to FY2019.
- To estimate and forecast the market size of India
erythromycin market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India erythromycin market
based on composition, application, source, form, distribution channel, route
of administration, end user, company, and regional distribution.
- To identify dominant region or segment in the India
erythromycin market.
- To identify drivers and challenges for India erythromycin
market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in India
erythromycin market.
- To identify and analyze the profile of leading
players operating in India erythromycin market.
- To identify key sustainable strategies adopted
by market players in India erythromycin market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of manufacturers across the globe. Subsequently, TechSci
Research conducted primary research surveys with the identified companies.
While interviewing, the respondents were also enquired about their competitors.
Through this technique, TechSci Research could include the manufacturers which
could not be identified due to the limitations of secondary research. TechSci
Research analyzed the manufacturers, distribution channels and presence of all
major players across the globe.
TechSci Research calculated the market size of India erythromycin market using a bottom-up approach, wherein data for various end-user segments
was recorded and forecast for the future years. TechSci Research sourced these
values from the industry experts and company representatives and externally
validated through analyzing historical data of these product types and
applications for getting an appropriate, overall market size. Various secondary
sources such as company websites, news articles, press releases, company annual
reports, investor presentations and financial reports were also studied by
TechSci Research.
Key Target Audience:
- Erythromycin manufacturers/
suppliers/ distributors
- Market research and
consulting firms
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums and
alliances related to erythromycin
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides allowing
them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, India erythromycin
market has been segmented into following categories, in addition to the
industry trends which have also been detailed below:
- India Erythromycin Market, By Composition:
- Erythromycin estolate
- Erythromycin stearate
- India Erythromycin Market, By Application:
- Respiratory Tract Infections
- Eye Infections
- Ear Infections
- Skin and Soft Tissue Infection
- Gastro-intestinal Infections
- Others
- India Erythromycin Market, By Source:
- In-house
- Contract Manufacturing Organizations
- India Erythromycin Market, By Form:
- Gel
- Tablet
- Capsule
- Injection
- Ointment
- Ear and Eye Drops
- India Erythromycin Market, By Distribution Channel:
- India Erythromycin Market, By Route of
Administration:
- Oral
- Topical
- Intravenous
- Otic
- Ophthalmic
- India Erythromycin Market, By End User:
- India Erythromycin Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India erythromycin market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed
analysis and profiling of additional market players (up to five).
India erythromycin market
is an upcoming report to be released soon. If you wish an early delivery of
this report or want to confirm the date of release, please contact us at [email protected]